Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

WHO’s TAG-VE group presented the most recent evidence on Omicron evolution and genetic diversity.

1 Nov 2022

How does the ISG15/ISGylation system modulate Vaccinia virus infection?

Researchers demonstrated how interferon-stimulated gene 15 (ISG15) is involved in the Vaccinia virus (VACV) dissemination.

1 Nov 2022

COVID-19 pandemic increased deaths and disease caused by tuberculosis

A new report published by the World Health Organization indicated a decrease in global spending on essential TB services from US$6 billion in 2019 to US$5.4 billion in 2021.

31 Oct 2022

SARS-CoV-2 Omicron BA.2 less severe than Delta and original Omicron

Researchers estimate the severity of infection with the SARS-CoV-2 Omicron BA.2 subvariant as compared to that caused by the Delta and Omicron variants.

31 Oct 2022

New research suggests booster dose of Novavax NVX-CoV2373 vaccine is effective against SARS-CoV-2 Omicron subvariants

A new study evaluated the neutralizing antibody titers against the SARS-CoV-2 Omicron variant and its sub-lineages after two and three doses of the Novavax protein nanoparticle vaccine NVX-CoV2373.

31 Oct 2022

What is the impact of SARS-CoV-2 on HIV-1 infectivity?

In a new study, researchers assessed the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV envelope (E) proteins on human immunodeficiency virus type 1 (HIV-1) infectivity.

31 Oct 2022

Italian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individuals

Researchers from Italy investigated the risk of SARS-CoV-2 reinfection and hospitalization among individuals with vaccinations and previous SARS-CoV-2 infections.

31 Oct 2022

SpyCatcher-SpyTag technology used to develop recombinant protein-based intranasal vaccine against SARS-CoV-2

The findings of a new study showed that the intranasal SpyCage vaccine platform can be protective against SARS-CoV-2 and may prove to be a versatile and adaptable modality for the formulation of intranasal vaccines that target respiratory pathogens.

31 Oct 2022

The impact of genetic and lifestyle factors on the risk of major cardiovascular and thromboembolic events post-COVID-19 diagnosis

A new study aimed to analyze the association between lifestyle risk factors, PRSs, and their interactions along with the risk of CVE within 90 days post-COVID-19 diagnosis.

31 Oct 2022

An innovative nasal vaccine strategy to combat COVID

In a recent study published in the journal Science, researchers at Yale University developed a novel coronavirus disease 2019 (COVID-19) vaccination strategy termed 'prime and spike' (P&S) that leveraged existing systemic immunity triggered by parenteral vaccination (prime) to boost immunity at the respiratory mucosa.

31 Oct 2022

Effects of SARS-CoV-2-associated stress among pregnant women on development of fetus brain

Researchers in the United States evaluated the effects of maternal coronavirus disease 2019 (COVID-19) pandemic-associated stress and fetal brain development using magnetic resonance imaging (MRI).

30 Oct 2022

Psychosocial impact on pandemic workers in Shanghai during Omicron wave lockdown

In a recent study posted to the medRxiv* server, researchers assessed the well-being of all workers involved in coronavirus disease 2019 (COVID-19) testing between April and June 2022, i.e., during the Omicron wave lockdown in Shanghai, China.

30 Oct 2022

How COVID-19 impacted sleep and mental health among university students

In a recent study published in the journal PLoS ONE, researchers evaluated the effects of coronavirus disease 2019 (COVID-19) on the sleep quality and mental health (MH) of university-attending undergraduate students.

30 Oct 2022

SARS-CoV-2 infection can affect menstruation

Researchers assess the association between SARS-CoV-2 infection and menstrual irregularities.

30 Oct 2022

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

In a recent study published in the journal JAMA Network Open, researchers in the United States estimated the sociodemographic factors associated with and prevalence of post-acute coronavirus disease 2019 (COVID-19) symptom sequelae (PASC) or long COVID (LCOVID).

30 Oct 2022

An evaluation of the response to nationwide COVID-19 testing in England

Researchers in the Netherlands and the United Kingdom formulated recommendations for future pandemics using lessons learned from the testing programs implemented in the United Kingdom (UK) during the ongoing coronavirus disease 2019 (COVID-19) pandemic.

30 Oct 2022